Affordable Access

Publisher Website

Cimetidine therapy for warts: A placebo-controlled, double-blind study

Authors
Journal
Journal of the American Academy of Dermatology
0190-9622
Publisher
Elsevier
Publication Date
Volume
34
Issue
6
Identifiers
DOI: 10.1016/s0190-9622(96)90279-0
Disciplines
  • Medicine

Abstract

Abstract Background: Cimetidine, an H 2-receptor antagonist, has been used successfully to treat patients with mucocutaneous candidiasis, common variable immunodeficiency, herpes simplex, and herpes zoster because of its immunomodulatory effects. Recently, some trials have suggested that cimetidine may also be useful for the treatment of warts. Objective: The aim of the present study was to determine whether cimetidine is effective in the treatment of warts. Methods: Seventy patients with multiple warts were included in a placebo-controlled, double-blind study. Patients were randomly allocated to treatment groups equally. The groups received cimetidine, 25 to 40 mg/kg daily, or placebo for 3 months. Patients were examined at monthly intervals. Results: At the end of the therapy, 28 cimetidine-treated and 26 placebo-treated patients were examined to determine the efficacy of treatment. Cure rates obtained were 32% (9 of 28) in the cimetidine-treated group and 30.7% (8 of 26) in the placebo-treated group. No significant difference was found between cimetidine and placebo in effectiveness ( p = 0.85). Conclusion: Our results show that cimetidine is no more effective than placebo in the treatment of patients with common warts.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Cimetidine therapy for warts: a placebo-controlled...

on Journal of the American Academ... June 1996

Is cimetidine effective for nongenital warts: a do...

on Archives of Dermatology April 1997

Cimetidine vs placebo: complete gastric ulcer pain...

on Acta gastroenterologica Latino... 1980

Therapy with garlic: results of a placebo-controll...

on British journal of clinical pr... August 1990
More articles like this..